Gilead lunch symposium

Saturday, February 25, 2023

12:30 PM - 1:45 PM

Boulevard Auditorium

Speakers

Dr. Michelle Yong

Dr Michelle Yong (MBBS FRACP MPH PhD) is an Infectious Diseases Physician and clinician researcher at Peter MacCallum Cancer Centre, The Royal Melbourne Hospital and the National Centre for Infections in Cancer, Australia. She has worked in the field of infections in transplantation and haematology for >15 years with specific interest in CMV and other opportunistic viral infections. She co-leads a clinical trials unit exploring novel viral and fungal therapeutics.

Dr. Tina Marinelli

Dr Tina Marinelli is an infectious diseases physician at Royal Prince Alfred Hospital, Sydney, Australia. She has a subspeciality interest in infections in immunocompromised hosts and completed post-fellowship training in transplant infectious diseases at Toronto General Hospital/University of Toronto. She is active in clinical research and her main focuses are invasive fungal infection and COVID-19 in solid organ transplant recipients.

Moderator

Prof. David Paterson

David Paterson is a tenured Professor of Medicine at the Saw Swee Hock School of Public Health and the Yong Loo Lin School of Medicine, both at the National University of Singapore. He is also an Honorary Professor at the University of Queensland. Professor Paterson directs ADVANCE-ID (ADVANcing Clinical Evidence for Infectious Diseases), a clinical trials network comprising more than 40 hospitals across Asia. This network is jointly funded by the Wellcome Trust and a number of Singaporean institutions with an aim to conduct clinically important trials in the field of antimicrobial resistance (AMR). This comprises trials of antibiotics, diagnostics and prevention strategies.

Gilead

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 40 countries worldwide, with headquarters in Foster City, California.

ASA

E: info@asainc.net.au
asainc.net.au

ICMS Pty Ltd

P: (+61) 3 9810 0200
E: antimicrobials@icms.com.au
icms.com.au